Cargando…

FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma

Myxoid liposarcoma is one of the most common sarcoma entities characterized by FET fusion oncogenes. Despite a generally favorable prognosis of myxoid liposarcoma, chemotherapy resistance remains a clinical problem. This cancer stem cell property is associated with JAK-STAT signaling, but the link t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dolatabadi, Soheila, Jonasson, Emma, Andersson, Lisa, Luna Santamaría, Manuel, Lindén, Malin, Österlund, Tobias, Åman, Pierre, Ståhlberg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851354/ https://www.ncbi.nlm.nih.gov/pubmed/35186752 http://dx.doi.org/10.3389/fonc.2022.816894

Ejemplares similares

JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2019)

The FUS-DDIT3 Interactome in Myxoid Liposarcoma()
por: Yu, Jamie S.E., et al.
Publicado: (2019)

Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses
por: Svec, David, et al.
Publicado: (2018)

Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo
por: Vannas, Christoffer, et al.
Publicado: (2022)

Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop
por: Andersson, Mattias K, et al.
Publicado: (2010)

DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2
por: Bento, Christoffer, et al.
Publicado: (2009)

Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma
por: Ståhlberg, Anders, et al.
Publicado: (2014)

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex
por: Lindén, Malin, et al.
Publicado: (2019)

DDIT3 Expression in Liposarcoma Development
por: Kåbjörn Gustafsson, Christina, et al.
Publicado: (2014)

Cell Senescence in Myxoid/Round Cell Liposarcoma
por: Kåbjörn Gustafsson, Christina, et al.
Publicado: (2014)

Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification
por: Murshed, Khaled A., et al.
Publicado: (2021)

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
por: Berthold, Ruth, et al.
Publicado: (2022)

A cryptic EWSR1 :: DDIT3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics
por: Ibstedt, Sebastian, et al.
Publicado: (2022)

FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma
por: Lindén, Malin, et al.
Publicado: (2022)

HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo
por: Safavi, Setareh, et al.
Publicado: (2015)

Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells
por: Suzuki, Kayo, et al.
Publicado: (2012)

Requirement for YAP1 signaling in myxoid liposarcoma
por: Trautmann, Marcel, et al.
Publicado: (2019)

Total mRNA Quantification in Single Cells: Sarcoma Cell Heterogeneity
por: Jonasson, Emma, et al.
Publicado: (2020)

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway()
por: Tornin, Juan, et al.
Publicado: (2017)

Aggressive myxoid liposarcoma of mediastinum.
por: Sharma, B. S., et al.
Publicado: (1992)

Retroperitoneal perirenal myxoid liposarcoma
por: Crisan, Nicolae, et al.
Publicado: (2015)

Primary Retroperitoneal Myxoid Liposarcomas
por: Setsu, Nokitaka, et al.
Publicado: (2016)

Recurrent myxoid liposarcoma of the hand
por: Boyd, Carter J., et al.
Publicado: (2019)

Management of myxoid liposarcoma of the extremity
por: Tfayli, Yehia, et al.
Publicado: (2021)

Primary Orbital Myxoid Liposarcoma
por: Benavides-Huerto, Miguel Armando, et al.
Publicado: (2023)

FUS-DDIT3 Prevents the Development of Adipocytic Precursors in Liposarcoma by Repressing PPARγ and C/EBPα and Activating eIF4E
por: Pérez-Mancera, Pedro A., et al.
Publicado: (2008)

The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response
por: Andersson, Mattias K, et al.
Publicado: (2008)

Subcutaneous Myxoid and Round Cell Liposarcoma
por: Roh, Hyun Soo, et al.
Publicado: (2011)

Imaging of Skeletal Metastases in Myxoid Liposarcoma
por: Noble, J. L., et al.
Publicado: (2010)

Primary myxoid liposarcoma of the supraglottic larynx
por: Gleinser, David M, et al.
Publicado: (2010)

Myxoid liposarcoma: it's a hippo's world
por: Regina, Carla, et al.
Publicado: (2019)

Prognostic factors of metastatic myxoid liposarcoma
por: Shinoda, Yusuke, et al.
Publicado: (2020)

Giant Mediastinal Myxoid Pleomorphic Liposarcoma
por: Al Kindi, Adil H., et al.
Publicado: (2023)

Global preamplification simplifies targeted mRNA quantification
por: Kroneis, Thomas, et al.
Publicado: (2017)

Multicentric myxoid liposarcoma: report of two cases
por: Fernández-Aceñero, M Jesus, et al.
Publicado: (2007)

Solitary breast metastasis from myxoid liposarcoma
por: Yokouchi, Masahiro, et al.
Publicado: (2014)

Giant myxoid liposarcoma of descending mesocolon origin
por: Uslukaya, Omer, et al.
Publicado: (2014)

About a case of paratesticular myxoid liposarcoma
por: Ayari, Yassine, et al.
Publicado: (2018)

Primary myxoid liposarcoma of the pelvis: An unusual location
por: Rico Gala, Susana, et al.
Publicado: (2020)

Myxoid liposarcoma of bladder: a rare case
por: Chudal, Sampanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t3h57m70mvc6c4160vmsp2n5jj